UBC Announces Acquisition of MarketShare Movers
Acquisition of data-driven prescription drug benefit and affordability company will ”help patients overcome financial barriers to starting and staying on therapy.”
UBC (Blue Bell, PA) has announced that it has acquired MarketShare Movers (MSM), a data-driven prescription drug benefit and affordability company.
“This acquisition enriches what we can offer to our current and future clients, inclusive of adding a full-service co-pay offering,” said Nicole Hebbert, Senior Vice President, UBC Patient Access Services. “The MSM Team will bring a specific expertise in modeling affordability programs to achieve optimal access to patients.”
Kevin Kane, founder of MarketShare Movers, added, “Using MSM’s consultative approach and proprietary analytics, UBC will now partner with clients to design and implement advanced and integrated patient co-pay benefit programs. This allows our clients to leverage our analysis and track the ongoing, multi-tiered impact of each benefit design and gross to net.”
UBC said it looks forward to bringing these capabilities to its current and future clients through comprehensive insights-based approaches to co-pay and affordability programs.
Newron, Myung In Pharm Form Partnership Centered Around Treating Schizophrenia in South Korea
January 14th 2025The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
